According to Haemonetics's latest financial reports the company's current EPS (TTM) is $4.28. In 2022 the company made an earnings per share (EPS) of $3.18 an increase over its 2021 EPS that were of $0.73.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $4.11 | 29.33% |
2022 | $3.18 | 334.45% |
2021 | $0.73 | -79.77% |
2020 | $3.61 | 36.31% |
2019 | $2.65 | 75.47% |
2018 | $1.51 | -363.15% |
2017 | -$0.57 | -207.1% |
2016 | $0.54 | -132.17% |
2015 | -$1.67 | -268.43% |
2014 | $0.99 | -19.45% |
2013 | $1.23 | -15.28% |
2012 | $1.45 | -37.33% |
2011 | $2.31 | 8.73% |
2010 | $2.13 | -5.62% |
2009 | $2.25 | 15.09% |
2008 | $1.96 | 4.04% |
2007 | $1.88 | 28.9% |
2006 | $1.46 | -25.43% |
2005 | $1.96 | 49.68% |
2004 | $1.31 | 55% |
2003 | $0.84 | -21.88% |
2002 | $1.08 | 12.58% |
2001 | $0.96 | -1248.48% |
2000 | -$0.08359 | -110.74% |
1999 | $0.78 | -379.39% |
1998 | -$0.28 | -243.48% |
1997 | $0.19 | -81.89% |
1996 | $1.07 |